Table 2.

Clinical characteristics of the CRC subgroup of 52 patients

Characteristics (n, except for age in years and PCI in score units)	Colorectal cancer
Age – mean years (95% CI)	55 (51–59)
Gender – Male/Female	21/31
IPC administered	37
SPIC	7
HIPEC	30
Oxaliplatin	12
Oxaliplatin + irinotecan	18
PCI – mean (95% CI)	21 (18–24)
CC score
0	27
1	5
2	4
3	16
Diagnosis
Colon	47
Rectum	5
Preoperative chemo	39
Oxaliplatin/5-FU ± bev	30
Oxaliplatin/5-FU + cet	1
Oxaliplatin/capecitabine ± bev	4
Irinotecan/5-FU + bev	1
Capecitabine	1
5-FU alone	2
Adjuvant systemic chemo	15
Oxaliplatin/5-FU ± bev	8
Irinotecan/5-FU ± bev	2
Capecitabine	1
5-FU alone	1
Missing data on drug	3

Abbreviations: CRC colorectal cancer, PCI peritoneal cancer index, IPC intraperitoneal chemotherapy, SPIC sequential postoperative intraperitoneal chemotherapy, HIPEC hyperthermic intraperitoneal chemotherapy, CC completeness of cytoreduction, Chemo chemotherapy, Bev bevacizumab, Cet cetuximab.